An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial.

Saved in:
Bibliographic Details
Title: An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial.
Authors: Lee KT; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States., McLeod B; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Egleston B; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, United States., Brown S; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Howe S; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Fetzer D; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Gutstein L; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Cacioppo C; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Clark D; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Domchek SM; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States., Ebrahimzadeh J; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Falcone D; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Ofidis D; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Griffin H; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Mim R; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Hernandez S; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Fleisher L; Department of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, PA, United States., Karpink K; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Selmani E; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Tahsin A; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Wagner L; Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston Salem, NC, United States., Weinberg M; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Yi-Wen K; Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA, United States., Wood E; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Bradbury AR; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, United States.; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, PA, United States.
Source: JMIR research protocols [JMIR Res Protoc] 2025 Aug 25; Vol. 14, pp. e72515. Date of Electronic Publication: 2025 Aug 25.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: JMIR Publications Country of Publication: Canada NLM ID: 101599504 Publication Model: Electronic Cited Medium: Internet ISSN: 1929-0748 (Electronic) Linking ISSN: 19290748 NLM ISO Abbreviation: JMIR Res Protoc Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1929-0748
DOI:10.2196/72515